| Literature DB >> 32620705 |
Poorva Jain1, Aisling M Chaney1, Mackenzie L Carlson1,2, Isaac M Jackson1, Anoushka Rao1, Michelle L James3,4.
Abstract
Neuroinflammation is a key pathologic hallmark of numerous neurologic diseases, however, its exact role in vivo is yet to be fully understood. PET imaging enables investigation, quantification, and tracking of different neuroinflammation biomarkers in living subjects longitudinally. One such biomarker that has been imaged extensively using PET is translocator protein 18 kDa (TSPO). Although imaging TSPO has yielded valuable clinical data linking neuroinflammation to various neurodegenerative diseases, considerable limitations of TSPO PET have prompted identification of other more cell-specific and functionally relevant biomarkers. This review analyzes the clinical potential of available and emerging PET biomarkers of innate and adaptive immune responses, with mention of exciting future directions for the field.Entities:
Keywords: biomarker validation; clinical imaging; molecular imaging; neuroinflammation; positron emission tomography
Mesh:
Substances:
Year: 2020 PMID: 32620705 PMCID: PMC7413228 DOI: 10.2967/jnumed.119.229443
Source DB: PubMed Journal: J Nucl Med ISSN: 0161-5505 Impact factor: 10.057